Efficacy and Treatment-Limiting Toxicity With the Concurrent Use of Lopinavir/Ritonavir and a Third Protease Inhibitor in Treatment-Experienced HIV-Infected Patients-Reference-Cited by-同舟云学术

Efficacy and Treatment-Limiting Toxicity With the Concurrent Use of Lopinavir/Ritonavir and a Third Protease Inhibitor in Treatment-Experienced HIV-Infected Patients

Published:2003-04 Issue:5 Volume:32 Page:494-498
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes

Author:

Casau Nathalie C.,Glesby Marshall J.,Paul Simon,Gulick Roy M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference12 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

3. The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

4. Using Pharmacokinetics to Optimize Antiretroviral Drug-Drug Interactions in the Treatment of Human Immunodeficiency Virus Infection

5. Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse‐Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1–Infected Protease Inhibitor–Experienced Patients

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV Infection;Drugs;2010-09

2. Effect of prescribed minimum benefits on the prevalence of possible drug-drug interactions of antiretroviral agents in a section of the private health care sector in South Africa: a 2 year comparative study;International Journal of Pharmacy Practice;2008-12

3. Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery;Journal of Leukocyte Biology;2006-08-14

4. Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen;AIDS;2006-05-12

5. Antiretroviral therapies for treatment-experienced patients: current status and research challenges;AIDS;2005-05-20